Lv1
90 积分 2026-01-13 加入
Efficacy and safety assessment of drug-eluting bead transarterial chemoembolization combined with molecular targeted agents or immunotherapy in unresectable hepatocellullar carcinoma: Real-world evaluation
3个月前
已完结
HPB P24 Comparison of outcomes of Deb-TACE in patients with HCC larger than 5cm compared with HCC less than 5cm
4个月前
已关闭
Change in liver function after selective TACE for unresectable hepatocellular carcinoma: JIVROSG-2001 PRESIDENT-ALBI, a secondary analysis of a multicenter randomized controlled trial
4个月前
已完结
皖公网安备34019202002308
